Acute Kidney Injury Treatment Market Driven by Robust Growth of Dialysis Centers; Set for US$ 3.6 Bn Valuation by 2029

Market

Market players are focusing on technology expansion to attain a competitive edge. How the Rise in Geriatric Population is Driving Growth of Acute Kidney Injury Market: New Report Analyzes

Future Market Insights, Dubai: FMI states in its recent study on the acute kidney injury treatment that the market will record a noteworthy CAGR of 8% through 2029. Demand for acute kidney injury is anticipated to continue surging particularly due to the increased global burden of acute kidney injury among people.

hospitals are likely to strengthen their grip on market revenue in the near term, as governments in numerous countries are developing various platforms by creating more treatment options.” says the FMI analyst.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-9399

Acute kidney injury Market – Important Highlights

  • According to injury type, the pre-renal injury segment is expected to dominate the acute kidney injury treatment market, owing to its more prevalence in patients with acute kidney injury.
  • By distribution channel, hospitals are anticipated to hold their dominance during the forecasted years
  • Tech-driven AKI treatment devices to gain traction due to their ability to deliver enhanced care and support
  • North America led by the US is estimated to hold the major market share, due to its advancement in technologies and major government investment in the healthcare section.

Acute kidney injury Market – Drivers

  • Rising awareness about health benefits and advancements in diagnostic technology and more product availability is likely to drive the market during the forecast period.
  • An increase in the global geriatric population will drive the market, as older people are prone to health complications.
  • Favorable government policies and guidelines around the world to invest more in healthcare sectors are encouraging market growth.

 

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-9399

 

Acute kidney injury Market – Restraints

  • Lack of early detection of the diseases and limited knowledge among people about kidney health is one of the key restraints.
  • Dialysis is a very costly process, which is followed by long hospital stays which created a financial burden for many people.

COVID-19 Impact on Acute kidney injury Market

The acute kidney injury market growth is expected to be hampered owing to the unprecedented COVID-19 pandemic. As several countries went into lockdown, frequent visits to the hospital got reduced by the patients and the main focus of the doctors shifted to bring this pandemic under control. However, the market is expected to experience a swift turnaround with the stabilization of the economy.

Competitive Landscape

The acute kidney injury market players are leaning towards the expansion of the production facilities besides opting for strategic collaborations to attain a competitive edge.

A few of the key companies functioning in the global market include Braun Melsungen, Baxter International, Inc., Asahi Kasei Medical Co., Ltd, Baxter International, Inc.

To have a deeper understanding of the market, you can purchase the report at https://www.futuremarketinsights.com/checkout/9399

About the Study

The study offers readers a comprehensive assessment of the acute kidney injury market. Global, regional, and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights based on product type (Dialysis, Drug Therapy, and others), injury(Pre-renal Injury, Intrinsic Renal Injury), distribution channel, and across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

 

Explore FMI’s Coverage of the healthcare Industry

Pharmaceutical intermediates market: Get insights on the pharmaceutical intermediates market through FMI’s report covering detailed quantitative and qualitative analysis for the projection period 2020-2030.

Autoclave Market: FMI’s exhaustive study on the autoclaves market covers the latest trends, innovations, key players, and popular strategies for the period 2020-2030.

Microbial Therapeutic Products Market: Obtain detailed analysis on the microbial therapeutic products market through FMI’s report covering competitive analysis, key regions, and segmental analysis for 2020-2030.

 

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centres in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

 

Contact

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/acute-kidney-injury-treatment-market

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”